TS Financial Group (TSFG)’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-150
Closed -$6K 806
2024
Q3
$6K Buy
+150
New +$5.47K ﹤0.01% 574

Other funds holding SBIO

TS Financial Group (TSFG)'s SBIO Position: Q4 2024 in Review

TS Financial Group (TSFG) sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2024, closing a stake of 150 shares — an estimated $6K sold.

TS Financial Group (TSFG) first reported a position in SBIO in Q3 2024 and held it in 1 quarter. The position peaked at $6K in Q3 2024. 35 funds tracked by Wall St. Rank hold SBIO as of Q4 2024.

  • TS Financial Group (TSFG) reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2024 after selling out during the quarter.
  • TS Financial Group (TSFG) sold 150 ALPS Medical Breakthroughs ETF shares in Q4 2024, an estimated $6K.
  • TS Financial Group (TSFG) first reported a position in ALPS Medical Breakthroughs ETF in Q3 2024 and held it in 1 quarter.
  • TS Financial Group (TSFG)'s ALPS Medical Breakthroughs ETF position peaked at $6K in Q3 2024.
  • 35 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2024.

Based on TS Financial Group (TSFG)'s 13F filing for Q4 2024, filed 13 Jan 2025.